Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 5Sarcoma 2Genitourinary 2Dermatologic 2Thoracic 1Head & Neck 1Gynecologic 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 108Carcinoma, Renal Cell 36Melanoma 13Kidney Neoplasms 13Neoplasm Metastasis 11Urinary Bladder Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Breast Neoplasms 9Brain Neoplasms 9Sarcoma 8Lung Neoplasms 8Prostate Cancer Metastatic 6Neoplasms 5Carcinoma, Transitional Cell 5Adenocarcinoma 5Prostate Adenocarcinoma 4Head and Neck Neoplasms 3Gastrointestinal Neoplasms 3Clear-cell metastatic renal cell carcinoma 3Thyroid Neoplasms 2Spinal Cord Compression 2Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Osteosarcoma 2Oligometastatic Prostate Cancer 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphatic Metastasis 2Local Recurrence of Malignant Tumor of Prostate 2Colorectal Neoplasms 2Colonic Neoplasms 2

Interventions

pembrolizumab 6sargramostim 5Psychiatric Rehabilitation 5Early Intervention, Educational 5Magnetic Resonance Spectroscopy 4Gemcitabine 4Cyclophosphamide 4palbociclib 3Trastuzumab 3Therapeutics 3Standard of Care 3Radiotherapy 3Oxaliplatin 3Methods 3Irinotecan 3Interferon-alpha 3Fluorouracil 3Fluorodeoxyglucose F18 3Erlotinib Hydrochloride 3Docetaxel 3Bortezomib 3temsirolimus 2motexafin gadolinium 2entinostat 2cemiplimab 2cediranib 2Specimen Handling 2Radiosurgery 2Practice Guidelines as Topic 2Paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colonic Neoplasms × Radiosurgery × Genitourinary × Clear all
NCT04498767 2024-08-26

OligoRARE

European Organisation for Research and Treatment of Cancer - EORTC

Phase NA Recruiting
200 enrolled
DermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

Urinary Bladder Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Melanoma, Pancreatic Neoplasms, Sarcoma, Skin Neoplasms, Stomach Neoplasms

NCT00587964 2016-02-22

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
51 enrolled 6 charts
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Sarcoma, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡